OpenURL Connection Search

Select item for more details and to access through your institution.

Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age‐related macular degeneration treated with bimonthly, treat‐and‐extend and as‐needed ranibizumab in the In‐Eye study
Published in:
Acta Ophthalmologica (1755375X), 2021, v. 99, n. 8, p. 861, doi. 10.1111/aos.14786
By:
- Saenz‐de‐Viteri, Manuel;
- Recalde, Sergio;
- Fernandez‐Robredo, Patricia;
- López Gálvez, María Isabel;
- Arias Barquet, Lluís;
- Figueroa, Marta S.;
- García‐Arumí, José;
- García‐Layana, Alfredo;
- Figueroa, Marta S;
- Rodríguez, Maribel Fernández;
- Arumí, Josep García;
- Amat, Pedro;
- Alicante, Vissum;
- Barquet, Lluís Arias;
- Moreno, Jose María Ruiz;
- Puyuelo, Javier Ascaso;
- Maresca, Félix Armada;
- Taulet, Enrique Cervera;
- Gálvez, María Isabel López;
- Imaz, Ramón Torres
Publication type:
Article
Bimonthly, treat‐and‐extend and as‐needed ranibizumab in naïve neovascular age‐related macular degeneration patients: 12‐month outcomes of a randomized study.
Published in:
Acta Ophthalmologica (1755375X), 2020, v. 98, n. 7, p. e820, doi. 10.1111/aos.14399
By:
- López Gálvez, María Isabel;
- Arias Barquet, Lluís;
- S. Figueroa, Marta.;
- García‐Layana, Alfredo;
- Ruiz Moreno, José M.;
- Fernandez Rodríguez, Maribel;
- García Arumí, Josep;
- Amat Peral, Pedro;
- Ascaso Puyuelo, Javier;
- Armada Maresca, Félix;
- Cervera Taulet, Enrique;
- Torres Imaz, Ramón;
- Gutierrez Sánchez, Estanislao;
- Cordovés Dorta, Luis Mateo;
- Esteban González, Eduardo;
- Velilla Osés, Sara;
- Abengoechea Hernández, Santiago;
- Ruiz Miguel, Miguel;
- Basauri Rementería, Erneesto;
- Caballos Castilla, Rafael
Publication type:
Article

Found: 2

Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age‐related macular degeneration treated with bimonthly, treat‐and‐extend and as‐needed ranibizumab in the In‐Eye study

Bimonthly, treat‐and‐extend and as‐needed ranibizumab in naïve neovascular age‐related macular degeneration patients: 12‐month outcomes of a randomized study.